Invited Speakers   Return
Xun Sun

Director & Professor of Department of Pharmaceutics

West China School of Pharmacy

Sichuan University

Dr. Xun Sun received her Ph.D. in Pharmaceutics from Sichuan University. After postdoctoral training at University of Pennsylvania and University of Michigan, she joined the faculty of Sichuan University in 2008 and became a Professor in 2012. Prof. Sun has authored or co-authored more than 100 peer-reviewed papers, filed 16 patents and contributed chapters to 5 books. Prof. Sun’s current research centers on the delivery of biopharmaceuticals, especially for vaccines and nucleic acid based therapeutics. She is the Associate Editor of Journal of Controlled Release and the Deputy Editor of Molecular Therapy. She also serves as the member of Chinese Pharmacopoeia Commission, the vice secretary general of the Pharmaceutical Association of Sichuan Province and the editorial board member of Acta Pharmaceutica Sinica B. Prof. Sun is the recipient of National Natural Science Funds for Distinguished Young Scientist, the Royal Society Newton Advanced Fellowship (UK), the Nagai Foundation Tokyo International Scholarship. She has received several scientific awards, including the Shulan Medical Prize, the first Prize of Sichuan Provincial Science and Technology Improvement Prize, Sichuan Youth Award for Science and Technology.


Representative Publications

[1]     Wenfei Chen, Zhaofei Guo, Yining Zhu, Nan Qiao, Zhirong Zhang, and Xun Sun*, Combination of Bacterial-Photothermal Therapy with an Anti-PD-1 Peptide Depot for Enhanced Immunity against Advanced Cancer. Adv. Funct. Mater. 1906623 (2019) (DOI: 10.1002/adfm.201906623)

[2]     Wenfei Chen, Ying Wang, Ming Qin, Xudong Zhang, Zhirong Zhang, Xun Sun*, Zhen Gu. Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy. ACS Nano. 12 5995-6005 (2018) (DOI: 10.1021/acsnano.8b02235)

[3]     Yuandong Zhang, Haibo Li, Qin Wang, Xinyan Hao, Hanmei Li, Heqiang Sun, Lu Han, Zhirong Zhang, Quanming Zou*, and Xun Sun*, Rationally Designed Self‐Assembling Nanoparticles to Overcome Mucus and Epithelium Transport Barriers for Oral Vaccines against Helicobacter pylori. Adv. Funct. Mater. 1802675 (2018) (DOI: 10.1002/adfm.201802675)

[4]     Hao Jiang, Qin Wang, Lin Li, Qin Zeng, Hanmei Li, Tao Gong, Zhirong Zhang, and Xun Sun*, Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8+ T Cell Responses. Advanced Science. 5 1700426 (2018) (DOI: 10.1002/advs.201700426)

[5]     Hanmei Li, Yao Fu, Ting Zhang, Yanping Li, Xiaoyu Hong, Jiayu Jiang, Tao Gong, Zhirong Zhang, and Xun Sun*, Rational Design of Polymeric Hybrid Micelles with Highly Tunable Properties to Co-Deliver MicroRNA-34a and Vismodegib for Melanoma Therapy. Adv. Funct. Mater. 25 7457–7469 (2015) (DOI: 10.1002/adfm.201503115)

[6]     Sanjun Shi, Lu Han, Tao Gong, Zhirong Zhang, and Xun Sun*, Systemic delivery of microRNA-34a for cancer stem cell therapy. Angewandte Chemie International Edition. 52 3901-3905 (2013) (DOI: 10.1002/anie.201208077)